 | Up a level |
Chan, A. T. C. and Lee, V. H. F. and Hong, R-L and Ahn, M. -J. and Chong, W. Q. and Kim, S. -B. and Ho, G. F. and Caguioa, P. B. and Ngamphaiboon, N. and Ho, C. and Aziz, M. A. S. A. and Ng, Q. S. and Yen, C. -J. and Soparattanapaisarn, N. and Ngan, R. K. -C and Kho, S. K. and Tiambeng, M. L. A. and Yun, T. and Sriuranpong, V. and Algazi, A. P. and Cheng, A. and Massarelli, E. and Swaby, R. F. and Saraf, S. and Yuan, J. and Siu, L. L. (2023) Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial. Annals of Oncology, 34 (3). pp. 251-261. ISSN 0923-7534, DOI https://doi.org/10.1016/j.annonc.2022.12.007.
Tan, W.S. and Low, W.Y. and Ng, C.J. and Tan, W.K. and Tong, S.F. and Ho, C. and Khoo, E.M. and Lee, G. and Lee, B.C. and Lee, V. and Tan, H.M. (2013) Efficacy and safety of long-acting intramuscular testosterone undecanoate in aging men: a randomised controlled study. BJU International, 111 (7). pp. 1130-1140. ISSN 1464-4096, DOI https://doi.org/10.1111/bju.12037.
